About Mestastop
Mestastop is a Healthcare company based in Bengaluru (India) founded in 2018 by Debabani Roy Chowdhury and Arnab Roy Chowdhury. Developer of cell-based functional assays for cancer metastasis focused drug discovery and predictive diagnostics. Mestastop has raised $1.29 million across 8 funding rounds from investors including Mumbai Angels, Malpani Ventures and IKP Knowledge Park. Mestastop was last valued at $4.75 million in May 2024. Its Indian entity Mestastop Solutions Private Limited reported revenue of ₹1.13 Cr. Mestastop offers products and services including Drug Discovery Platform, Drug Repurposing Service, and Clinical Translations Tool. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Drug Discovery.
Company details
Mestastop was established in 2018 in Bengaluru, India, within the biotechnology sector. Focus is placed on cell-based functional assays for drug discovery and predictive diagnostics targeting cancer metastasis. A platform including Metaassay, Metvivo, and Metscan is employed to evaluate compounds via in vitro tests for metastasis inhibition potential. Lead molecules are advanced through genetically engineered xenograft models to support research progression.
- Headquarters Bengaluru, India
- Founders Debabani Roy Chowdhury, Arnab Roy Chowdhury
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website mestastop.com
- Social LinkedIn X YouTube
- Legal Name Mestastop Solutions Private Limited
- Date of Incorporation 06 Sep, 2018
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹1.13 Cr
FY 2025 · +743% YoY
- Net Loss-₹2.58 Cr
FY 2025 · -227% margin
- EBITDA-₹2.39 Cr
FY 2025 · -211% margin
- Total Equity Funding$1.29M (USD)
in 8 rounds
- Latest Funding Round$315.12K (USD), Grant
Nov 2024
- InvestorsMumbai Angels
& 27 more
Associated legal entities of Mestastop
Mestastop operates through Mestastop Solutions Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mestastop Solutions Private Limited CIN U73100KA2018PTC116083 | Active | 06 Sep 2018 | Bangalore, Karnataka | ₹1.1 Cr | 5 | View details |
Products & Services of Mestastop
Mestastop offers a comprehensive portfolio of products and services, including Drug Discovery Platform, Drug Repurposing Service, and Clinical Translations Tool.
System for identifying novel cancer targets in translational settings
Method to repurpose drugs for delaying cancer metastasis
Machine learning approach for accurate pre-clinical study designs
Apps and channels of Mestastop
its YouTube channel Mestastop Solutions has 48 subscribers.
Funding Insights of Mestastop
Mestastop has successfully raised a total of $1.29M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $315.12 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.29M
- Total Rounds 8
- Last Round Grant — $315,122
- Investors Count 28
All 8 funding rounds of Mestastop with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $315,122 | Grant | – | – | |
| May 2024 | $131,716 | Seed | $4.75M | 92 Angels, Madrigal Ventures | |
| Dec 2023 | $156,371 | Seed | – | IKP Knowledge Park, IIMA Ventures | – |
| Aug 2023 | $685,248 | Seed | $4.65M | 92 Angels, Malpani Ventures | |
| Dec 2020 | $245,365 | Seed | $••••• | IKP Knowledge Park, IIMA Ventures | |
| Sep 2020 | Seed | – | Mumbai Angels | – | |
| Jul 2020 | $67,294 | Angel Round | $••••• | Arjun Surya | |
| Jun 2019 | Grant | – | – |
| Date | Valuation | Stage |
|---|---|---|
| May 2024 | $4.75M | •••••••• |
| Aug 2023 | $4.65M | •••••••• |
| Dec 2020 | $••••• | •••••••• |
| Jul 2020 | $••••• | •••••••• |
Full valuation and stage history of Mestastop
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $4.75M (May 2024). 28 investors in total: 8 institutional and 20 angel.
Investors in Mestastop
Mestastop has secured backing from 28 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Mumbai Angels, Malpani Ventures and IKP Knowledge Park.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Business incubation services are provided across multiple sectors. | birac.nic.in | Delhi, India | ||
Angel network focused on pre-seed & seed-stage startups | 92angels.com | New York, United States | ||
Med-tech startups are incubated by IKP Knowledge Park. | 1999 | ikpknowledgepark.com | Hyderabad, India | |
Early-stage tech startups are supported via venture capital and acceleration. | iimaventures.com | Ahmedabad, India | ||
Angel investment firm funding frugal innovation in India. | malpaniventures.com | Mumbai, India | ||
Early-stage venture investments are facilitated by Mumbai Angels network. | 2006 | mumbaiangels.com | Mumbai, India | |
Venture capital firm focused on companies led by women | 2018 | vistariventures.com | Chennai, India | |
AM Anirudh Malpani | Angel investor, IVF specialist, and founder of Malpani Infertility Clinic. | unknown_fcbd1879fdd247078 | ||
RA Rachna Aggarwal Sirdeshmukh | unknown_027cefcbc2e64d64a |
Investor details for Mestastop
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Mestastop Solutions Private Limited (Mestastop)
Mestastop Solutions Private Limited is the primary company behind Mestastop. The board of Mestastop Solutions Private Limited currently have 5 directors; the longest-serving is Debabani Roy Chowdhury, appointed in 2018. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Debabani Roy Chowdhury DIN 08217062 | Director | 06 Sep 2018 | 8 yrs 1 mo | Mestastop Solutions Private Limited |
| Arnab Roy Chowdhury DIN 08217061 | Director | 06 Sep 2018 | 8 yrs 1 mo | Mestastop Solutions Private Limited |
| Praveen Agarwal DIN 00429376 | Director | 23 Sep 2019 | 7 yrs 1 mo | Mestastop Solutions Private Limited |
| John Watson Ellingboe DIN 10492974 | Director | 08 Feb 2024 | 2 yrs 8 mo | Mestastop Solutions Private Limited |
| Ajith Vaman Kamath DIN 10481359 | Director | 08 Feb 2024 | 2 yrs 8 mo | Mestastop Solutions Private Limited |
People of Mestastop
14 people are tracked at Mestastop (3 in leadership, 2 in board & advisors, 9 in team).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
| Director, Finance | Leadership | |
| Advisor | Board & advisors | |
| Scientific Advisor | Board & advisors | |
Chinmaya A | Principal Scientist | Team |
Saif Wahid | Senior Scientist | Team |
Ayushi Gandhi | Junior Research Associate | Team |
Judhajit Sanyal | Senior Data Scientist | Team |
Amit Sharma | Consultant | Team |
Nikhil Babu | Senior Research Associate | Team |
Ashwathi Rajeevan | Research Scientist | Team |
Reeta Singh | Research Scientist | Team |
Varshini S N | Laboratory Attendant | Team |
Complete people profiles for Mestastop
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Mestastop
Figures of Mestastop Solutions Private Limited, the primary company behind Mestastop, for FY 2025. Revenue was ₹1.13 Cr (+743% year on year). Net loss was -₹2.58 Cr (-227% margin). EBITDA was -₹2.39 Cr (-211% margin). Revenue has grown at a compounded annual rate of +90% over three years.
- ₹1.13 CrRevenue · FY 2025 · +743% YoY
- -₹2.58 CrNet loss · -227% margin
- -₹2.39 CrEBITDA · -211% margin
- ₹1.5 LakhPaid-up capital
- +90%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Mestastop Solutions Private Limited are on its company page.
Detailed financial statements for Mestastop
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Mestastop
4 dated milestones of Mestastop across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Mestastop is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Grant, of $315K.
Web traffic of Mestastop
The website of Mestastop (mestastop.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 3.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mestastop
Complete news archive for Mestastop
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mestastop
Mestastop was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Mestastop is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Mestastop is a funded company, having raised a total of $1.29M across 8 funding rounds to date.
The primary company behind Mestastop, Mestastop Solutions Private Limited, reported revenue of ₹1.13 Cr for FY 2025, up 743% year on year.
Mestastop was established in 2018 in Bengaluru, India, within the biotechnology sector. Focus is placed on cell-based functional assays for drug discovery and predictive diagnostics targeting cancer metastasis. A platform including Metaassay, Metvivo, and Metscan is employed to evaluate compounds via in vitro tests for metastasis inhibition potential. Lead molecules are advanced through genetically engineered xenograft models to support research progression.
Mestastop offers Drug Discovery Platform, Drug Repurposing Service, and Clinical Translations Tool.
Mestastop has 28 investors. Key investors include Mumbai Angels, Malpani Ventures, IKP Knowledge Park, Vistari Venture Partners, and BIRAC.
The valuation of Mestastop is $4.75M as of May 2024.
Mestastop operates through Mestastop Solutions Private Limited.
The legal entities of Mestastop currently have 5 directors, including John Watson Ellingboe, Ajith Vaman Kamath, Praveen Agarwal and others.